Ezhov 2014 [68] reported that stable CHD patients with Lp(a) ≥30 mg/dL were at a significantly greater risk of cardiovascular death and MI (HR 2.98, 95 % confidence interval [CI]: 1.76 to 5.03) and cardiovascular death, MI, hospitalization for recurrent or unstable angina and repeat revascularization (HR 3.47, 95 % CI: 2.48 to 4.85), than patients with Lp(a) values <30 mg/dL. The gene discussed is LPA; the disease is angina pectoris.